Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James M Brophy

Showing results (171-180 of 245) with videos related to

Pageof 25
Sort By:
Archives of Internal Medicine|June 10, 2009
Continuation of statin treatment and mortality: a note of caution on excessive benefitsKristian B Filion, Verena Schneider-Lindner, Igor Karp, et al.
Archives of Internal Medicine|January 26, 2005
Fluctuating inflammatory markers in patients with stable ischemic heart diseasePeter Bogaty, James M Brophy, Luce Boyer, et al.
Circulation|August 11, 2004
Impact of prolonged cyclooxygenase-2 inhibition on inflammatory markers and endothelial function in patients with ischemic heart disease and raised C-reactive protein: a randomized placebo-controlled studyPeter Bogaty, James M Brophy, Martin Noel, et al.
Current Drug Safety|June 6, 2012
Irritable bowel syndrome and drospirenone-containing oral contraceptives; a comparative-safety studySteven T Bird, Wei Liu, James M Brophy, et al.
BMC Clinical Pharmacology|January 3, 2012
The association between drospirenone and hyperkalemia: a comparative-safety studySteven T Bird, Salvatore R Pepe, Mahyar Etminan, et al.
The American Journal of Cardiology|March 10, 2010
Usefulness of soluble fas levels for improving diagnostic accuracy and prognosis for acute coronary syndromesHéloise Cardinal, James M Brophy, Peter Bogaty, et al.
BMJ (Clinical Research Ed.)|May 11, 2017
Risk of acute myocardial infarction with NSAIDs in real world use: bayesian meta-analysis of individual patient dataMichèle Bally, Nandini Dendukuri, Benjamin Rich, et al.
BMC Health Services Research|July 11, 2006
The risk of death associated with delayed coronary artery bypass surgeryBoris G Sobolev, Adrian R Levy, Lisa Kuramoto, et al.
The American Journal of Cardiology|June 12, 2010
Genetic polymorphisms and the cardiovascular risk of non-steroidal anti-inflammatory drugsChristine G St Germaine, Peter Bogaty, Luce Boyer, et al.
Plos One|April 13, 2013
Time variability of C-reactive protein: implications for clinical risk stratificationPeter Bogaty, Gilles R Dagenais, Lawrence Joseph, et al.
Pageof 25

Showing results (171-180 of 245) with videos related to

Sort By:
Pageof 25
Archives of Internal Medicine|June 10, 2009
Continuation of statin treatment and mortality: a note of caution on excessive benefitsKristian B Filion, Verena Schneider-Lindner, Igor Karp, et al.
Archives of Internal Medicine|January 26, 2005
Fluctuating inflammatory markers in patients with stable ischemic heart diseasePeter Bogaty, James M Brophy, Luce Boyer, et al.
Circulation|August 11, 2004
Impact of prolonged cyclooxygenase-2 inhibition on inflammatory markers and endothelial function in patients with ischemic heart disease and raised C-reactive protein: a randomized placebo-controlled studyPeter Bogaty, James M Brophy, Martin Noel, et al.
Current Drug Safety|June 6, 2012
Irritable bowel syndrome and drospirenone-containing oral contraceptives; a comparative-safety studySteven T Bird, Wei Liu, James M Brophy, et al.
BMC Clinical Pharmacology|January 3, 2012
The association between drospirenone and hyperkalemia: a comparative-safety studySteven T Bird, Salvatore R Pepe, Mahyar Etminan, et al.
The American Journal of Cardiology|March 10, 2010
Usefulness of soluble fas levels for improving diagnostic accuracy and prognosis for acute coronary syndromesHéloise Cardinal, James M Brophy, Peter Bogaty, et al.
BMJ (Clinical Research Ed.)|May 11, 2017
Risk of acute myocardial infarction with NSAIDs in real world use: bayesian meta-analysis of individual patient dataMichèle Bally, Nandini Dendukuri, Benjamin Rich, et al.
BMC Health Services Research|July 11, 2006
The risk of death associated with delayed coronary artery bypass surgeryBoris G Sobolev, Adrian R Levy, Lisa Kuramoto, et al.
The American Journal of Cardiology|June 12, 2010
Genetic polymorphisms and the cardiovascular risk of non-steroidal anti-inflammatory drugsChristine G St Germaine, Peter Bogaty, Luce Boyer, et al.
Plos One|April 13, 2013
Time variability of C-reactive protein: implications for clinical risk stratificationPeter Bogaty, Gilles R Dagenais, Lawrence Joseph, et al.
Pageof 25